The combined U.S. market for percutaneous vertebroplasty and vertebral augmentation products and thermal intradiscal devices is projected to increase at a compound annual rate of 2.5% during the forecast period covered by this report (from 2011 to 2016).
This dynamic new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of percutaneous vertebroplasty and vertebral augmentation products and thermal intradiscal devices. The market segments that are covered by this report include percutaneous vertebroplasty and kyphoplasty systems and thermal intradiscal devices (including nucleoplasty and intradiscal biacuplasty and electrothermal therapy products).
EXECUTIVE SUMMARY i. Selected Spinal Disorders a. Degenerative Disc Disease b. Disc Herniation c. Spinal Tumors d. Traumatic Spinal Injuries e. Vertebral Fractures ii. Percutaneous Vertebroplasty and Vertebral Augmentation Products Market a. Market Analysis iii. Percutaneous Thermal Intradiscal Products Market a. Intradiscal Biacuplasty b. Intradiscal Electrothermal Therapy c. Plasma Disc Decompression d. Market Analysis iv. Combined Market Forecast v. Methodology Exhibit ES-1: Prevalence of Selected Spinal Disorders, 2011-2016 Exhibit ES-2: Incidence of Selected Spinal Disorders, 2011-2016 Exhibit ES-3: Vertebroplasty and Vertebral Augmentation Products, Market Forecast, 2011-2016 Exhibit ES-4: Percutaneous Thermal Intradiscal Products, Market Forecast, 2011-2016 Exhibit ES-5: Percutaneous Vertebroplasty/Vertebral Augmentation and Thermal Intradiscal Products, Combined Market Forecast, 2011-2016 1. CLINICAL OVERVIEW 1.1 The Human Spine 1.2 Bone Structure and Function 1.2.1 Bone Formation 1.2.2 Cellular Framework 184.108.40.206 Osteoblasts 220.127.116.11 Osteocytes 18.104.22.168 Osteoclasts 1.2.3 The Fracture Healing Process 1.2.4 Factors Affecting Bone Physiology 22.214.171.124 The Effect of Physical Stress on Bone Remodeling 126.96.36.199 Age and Gender 188.8.131.52 Physical Activity 184.108.40.206 Obesity 220.127.116.11 Cigarette Smoking, Alcohol, and Caffeine 18.104.22.168 Nutritional Deficiencies 1.3 Selected Spinal Disorders 1.3.1 Disc Herniation 1.3.2 Degenerative Disc Disease 22.214.171.124 Arthritis 126.96.36.199.1 Osteoarthritis 188.8.131.52.2 Rheumatoid Arthritis 184.108.40.206.3 Ankylosing Spondylitis 220.127.116.11 Osteoporosis 18.104.22.168 Spondylosis 1.3.3 Abnormal Curvature of the Spine 22.214.171.124 Scoliosis 126.96.36.199 Kyphosis and Lordosis 1.3.4 Spondylolisthesis 1.3.5 Stenosis 1.3.6 Spinal Tumors 1.3.7 Traumatic Spinal Injuries 1.3.8 Vertebral Fractures 1.4 Spine Treatment Options 1.4.1 Spinal Decompression 188.8.131.52 Corpectomy 184.108.40.206 Discectomy 220.127.116.11 Facetectomy 18.104.22.168 Foraminotomy/Foraminectomy 22.214.171.124 Laminotomy/Laminectomy 1.4.2 Spinal Fusion 126.96.36.199 Instrumented versus Noninstrumented Spinal Fusion 188.8.131.52.1 Instrumented Spinal Fusion 184.108.40.206.2 Noninstrumented Spinal Fusion 220.127.116.11 Types of Fusion 18.104.22.168.1 Cervical Fusion 22.214.171.124.2 Anterior Cervical Fusion 126.96.36.199.3 Posterior Cervical Fusion 188.8.131.52.4 Interbody Fusion 184.108.40.206.5 Lumbar Fusion 220.127.116.11.5.1 Anterior Lumbar Interbody Fusion 18.104.22.168.5.2 Posterior Lumbar Interbody Fusion 22.214.171.124.5.3 Transforaminal Lumbar Interbody Fusion 126.96.36.199.6 Posterolateral Fusion 188.8.131.52.7 360-Degree Fusion 184.108.40.206.8 Thoracic and Thoracolumbar Fusion 220.127.116.11.9 Percutaneous or Minimally Invasive Fusion 1.4.3 Posterior Dynamic Stabilization 1.5 Market Dynamics 1.5.1 Demographics 1.5.2 Reimbursement 1.5.3 Patient Protection and Affordable Care Act 1.5.4 Federal Oversight of Physician/Corporate Relationships 1.5.5 Procedure Volumes Forecast Exhibit 1-1: The Human Spine Exhibit 1-2: The Structure of Collagen Exhibit 1-3: The Structure of Hydroxyapatite Exhibit 1-4: The Structure of Bone Exhibit 1-5: Bone Density Averages in the General Population Exhibit 1-6: Bone Density Averages in Olympic Athletes in Comparison with the General Population Exhibit 1-7: Number of Overweight and Obese People, 2011 and 2016 Exhibit 1-8: A Herniated Disc Exhibit 1-9: Bone Density in Normal and Osteoporotic Bone Tissue Exhibit 1-10: Prevalence of Selected Spinal Disorders, 2011-2016 Exhibit 1-11: Incidence of Selected Spinal Disorders, 2011-2016 Exhibit 1-12: The Anatomy of a Spinal Segment Exhibit 1-13: Noninstrumented Spinal Fusion Exhibit 1-14: United States Population Growth Trends Exhibit 1-15: Spinal Fusion Diagnosis-Related Groups and Associated Medicare Reimbursement Exhibit 1-16: Spinal Fusion, Procedure Volumes Forecast, 2010-2016 2. PERCUTANEOUS VERTEBROPLASTY AND VERTEBRAL AUGMENTATION PRODUCTS MARKET 2.1 Vertebroplasty 2.1.1 Polymethylmethacrylate Alternatives 2.2 Kyphoplasty 2.3 Technology Assessments 2.4 Reimbursement 2.5 Vertebroplasty Products 2.6 Percutaneous Vertebral Augmentation Products 2.6.1 Emerging Vertebral Augmentation Products 2.7 Market Analysis 2.8 Competitive Analysis Exhibit 2-1: The Vertebroplasty Procedure Exhibit 2-2: Vertebroplasty Indications and Contraindications Exhibit 2-3: The Balloon Kyphoplasty Procedure Exhibit 2-4: 2012, Percutaneous Vertebroplasty, Medicare Physician Reimbursement Exhibit 2-5: 2012, Percutaneous Vertebral Augmentation, Medicare Physician Reimbursement Exhibit 2-6: 2012, Percutaneous Vertebral Augmentation and Percutaneous Vertebroplasty, Medicare Hospital Inpatient, Possible MS-DRG Groups Exhibit 2-7: 2012, Percutaneous Vertebroplasty, Medicare Hospital Outpatient and Ambulatory Surgery Center Reimbursement Exhibit 2-8: 2012, Percutaneous Vertebral Augmentation, Medicare Hospital Outpatient and Ambulatory Surgery Center Reimbursement Exhibit 2-9: 2012, Selected Vertebroplasty Products Exhibit 2-10: 2012, Selected Percutaneous Vertebral Augmentation Products Exhibit 2-11: 2012, Selected Emerging Vertebroplasty and Vertebral Augmentation Products Exhibit 2-12: Vertebroplasty and Vertebral Augmentation Products, Market Forecast, 2011-2016 Exhibit 2-13: 2011, Vertebroplasty and Vertebral Augmentation Products Market, Share by Supplier 3. PERCUTANEOUS THERMAL INTRADISCAL PRODUCTS MARKET 3.1 Intradiscal Annuloplasty 3.1.1 Intradiscal Biacuplasty 3.1.2 Intradiscal Electrothermal Therapy 3.2 Plasma Disc Decompression 3.3 Clinical Trials 3.3.1 Intradiscal Biacuplasty 3.3.2 Intradiscal Electrothermal Therapy 3.3.3 Nucleoplasty 3.4 Reimbursement 3.5 Emerging Technology 3.6 Market Analysis 3.7 Competitive Analysis Exhibit 3-1: Intradiscal Biacuplasty Using the TransDiscal System Exhibit 3-2: The SpineCath Intradiscal Catheter Exhibit 3-3: The Plasma Disc Decompression Procedure Exhibit 3-4: 2012, Selected Percutaneous Thermal Intradiscal Products Exhibit 3-5: Percutaneous Thermal Intradiscal Products, Market Forecast, 2011-2016 Exhibit 3-6: 2011, Percutaneous Thermal Intradiscal Products Market, Share by Supplier 4. COMPANY PROFILES 4.1 ArthroCare Corporation 4.2 CareFusion Corporation 4.3 Medtronic, Inc. 4.4 NeuroTherm, Inc. 4.5 Stryker Corporation APPENDIX: COMPANY LISTING